Zhovtis RyersonLFrohmanTCFoleyJ, et al. Extended interval dosing of natalizumab in multiple sclerosis. J Neurol Neurosurg Psychiatry2016; 87(8): 885–889.
2.
TanakaMKinoshitaMFoleyJF, et al. Body weight-based natalizumab treatment in adult patients with multiple sclerosis. J Neurol2015; 262: 781–782.
3.
Van KempenZLRispensTKillesteinJ.The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing. Mult Scler2018; 24(6): 822–823.
4.
KhatriBOManSGiovannoniG, et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology2009; 72(5): 402–409.
